Indie Semiconductor (INDI) Suffers Q1 Drop from Tariff Woes

Indie Semiconductor (INDI) experienced a rough first quarter due to uncertainty surrounding tariffs. The company's stock dropped by over 10% in Q1, causing concern among investors. This decline can be attributed to the ongoing trade tensions between the US and China, as well as other factors affecting the semiconductor industry. Tariffs have been a hot topic in the news lately, and their impact on the stock market is evident. Indie Semiconductor is just one example of a company feeling the effects ...
Read More About This
|

The Price of Apple: What Jim Cramer is Asking

Apple Inc. (AAPL) has been a hot topic in the market lately, with many investors and analysts wondering if the tech giant's stock price is justified. However, CNBC's Jim Cramer is taking a different approach and asking a more specific question: what exactly are we paying for when we invest in Apple? Cramer points out that Apple's stock has been on a steady rise, reaching a market cap of $2.14 trillion. But he questions what justifies this valuation. Is it the ...
Read More About This
|

Morgan Stanley Bullish on Axsome Therapeutics (AXSM)

Morgan Stanley, one of the world's leading financial institutions, has recently assumed coverage of Axsome Therapeutics (AXSM) and given it an "overweight" rating. This comes as no surprise to many in the investment world, as Axsome has been making waves with its innovative treatments for neurological disorders. Axsome Therapeutics specializes in developing therapies for central nervous system (CNS) disorders, with a focus on depression and migraines. The company's flagship drug, AXS-05, has shown promising results in treating major depressive disorder and ...
Read More About This
|

“Morgan Stanley Bullish on Axsome Therapeutics, Here’s Why”

Morgan Stanley has just started covering Axsome Therapeutics (AXSM) with an overweight rating, signaling confidence in the company's potential for growth. This comes as no surprise, as Axsome has been making significant strides in the biotech industry with its innovative treatments for central nervous system disorders. The company's lead drug candidate, AXS-05, has shown promising results in treating major depressive disorder and Alzheimer's disease agitation, with potential for approval from the FDA in the near future. This, coupled with a strong ...
Read More About This
|

“Financial Firm Names Microsoft Its Top Pick for Investors”

Looking for a solid investment opportunity? Look no further than Microsoft (MSFT), according to financial firm DA Davidson. The company recently named Microsoft as its top mega-cap pick, with a new target set at $600. So why is Microsoft a top choice for investors? First and foremost, the company has consistently delivered strong earnings growth, with a 33% increase in the last quarter alone. This impressive performance is driven by the company's successful transition to a subscription-based business model, as well ...
Read More About This
|

Jim Cramer Gives Thumbs Up to Joby Aviation

If you're a retail investor looking for potential opportunities in the aviation industry, then you'll want to pay attention to what Jim Cramer has to say. The renowned financial expert recently discussed Joby Aviation, a company that specializes in electric vertical takeoff and landing (eVTOL) aircraft. And his verdict? He's not going to fight against it. So what does this mean for investors? Well, Joby Aviation is currently in the process of going public through a merger with a special purpose ...
Read More About This
|

“PodcastOne (NASDAQ:PODC) Q4 Earnings Call Highlights and Insights”

PodcastOne (NASDAQ:PODC) recently released its Q4 2025 earnings call transcript, providing valuable insights for investors and traders. Here are the key takeaways from the call: 1. Strong Revenue Growth: PodcastOne reported a 15% increase in revenue compared to the same quarter last year, driven by a significant increase in advertising sales. This growth is a positive sign for the company's future prospects and highlights the potential of the podcast industry. 2. Strategic Partnerships: During the call, PodcastOne CEO mentioned the company's partnerships ...
Read More About This
|

“Top Hedge Funds and Insider Trades to Watch Now”

Hedge funds and insider trading are always hot topics in the world of investing, and the latest news has some big names making moves. Here's a rundown of what's been happening and how it could impact your portfolio. Ray Dalio's Bridgewater Associates, one of the world's largest hedge funds, recently increased its position in Simon Property Group Inc (SPG). This move comes after SPG's stock took a hit during the pandemic, but with the economy slowly reopening, Dalio seems to have ...
Read More About This
|